HCM
ZBH icon

Hodges Capital Management’s Zimmer Biomet ZBH Stock Holding History

Hodges Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,957
Closed -$241K – 264
2021
Q4 		$241K Buy
+1,957
New +$256K 0.02% 228

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hodges Capital Management's ZBH Position: Q1 2022 in Review

Hodges Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 1,957 shares — an estimated $241K sold.

Hodges Capital Management first reported a position in ZBH in Q4 2021 and held it in 1 quarter. The position peaked at $241K in Q4 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

  • Hodges Capital Management reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
  • Hodges Capital Management sold 1,957 Zimmer Biomet shares in Q1 2022, an estimated $241K.
  • Hodges Capital Management first reported a position in Zimmer Biomet in Q4 2021 and held it in 1 quarter.
  • Hodges Capital Management's Zimmer Biomet position peaked at $241K in Q4 2021.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Hodges Capital Management's 13F filing for Q1 2022, filed 12 May 2022.